Long-term impact of up-front ASCT combined with Rituximab in Non Hodgkin Lymphoma (NHL): an analysis of toxicity and fatigue in Lymphoma Study Association (LYSA) trials, the SIMONAL study

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-term impact of up-front ASCT combined with Rituximab in Non Hodgkin Lymphoma (NHL): an analysis of toxicity and fatigue in Lymphoma Study Association (LYSA) trials, the SIMONAL study
Type de publicationJournal Article
Year of Publication2017
AuteursMounier N., Busson R., Anthony S., Thieblemont C., Nerich V., Ribrag V., Castera M., Tilly H., Haioun C., Casasnovas R-O, Morschhauser F., Feugier P., Delarue R., Ysebaert L., Sebban C., Fruchart C., Jais J-P, Henri-Amar M., Salles G., Gisselbrecht C.
JournalBONE MARROW TRANSPLANTATION
Volume52
PaginationS94
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0268-3369